📇 Rhumatologue ·
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
50 articles scientifiques publiés — un praticien à la pointe de la recherche
Référence presse grand public
Cité 6 fois dans les médias — pédagogie reconnue
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
21
21 articles ont été cités au moins 21fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
h-index
Total citations reçues
1 350
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
104
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
33
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Outcomes of clinical pharmacists with extended prescribing rights in a hemodialysis unit
2026ArticleJournal of the American Pharmacists Association : JAPhA
Early use of hybrid closed-loop following total pancreaticoduodenectomy.
2025ArticleDiabetes & Metabolism
Liver transplantation: Do not abandon T-tube drainage—a multicentric retrospective study of the ARCHET research group
2024ArticleUpdates in Surgery
Liver transplantation and hepatocellular carcinoma: is TIPS deleterious? A multicentric retrospective study of the ARCHET research group with propensity score matching
2023ArticleLangenbeck's Archives of Surgery
Positive Effects of an Escape Room Game on Members of a Pharmacy Department
2023ArticleThe Canadian journal of hospital pharmacy
Characterisation of a CCS storage site. Example from PilotStrategy European project
2023CongrèsEAGE SPE WORKSHOP CCS Evaluation: From Geoscience to the Economics
Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study
2023ArticleBJS Open
Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study
2021ArticleHPB
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Actu.fr · 28/01/2026
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOUncybEszQjFZWVYwN0tZR2JsQnkxMnJfUU5ZVnI3Q3JzcDJ1M1FnY2FKclFoWGpYSjdDOG1JNVB3M2RtRGw0cXpEbzFPNE15dUwwbVFHaHp1LXYxaG5XWTdvWEllWDR4Y3FOeVp3bGhELXFRWjJaT1RQbWl1aVNCR2RfXzdEMnZpMjBUVVVCMktuYXVVVThwSE9CdUVjbTBqSnoyUTJVUlJaLWJtVWc?oc=5" target="
📰 Actu.fr · 10/08/2025
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOTVd2MmVUbkh6Y3VXMDhPRUJBNGNMQWVkbVM3encyUFN6MEVTSHhmc0lVc183d2drYUdPSWhOUjlMSVZwTWYxYUQtanc5OEZEUEp2OGlrSk5Oa1pFc3hSVEhkTVRGc292VmhXWjJfSTNBZzJuTDJkdE5IUWpLNm1obE91dzMxcEFRZjRvSExJZXZ0ZmhMMXE0REZoU0gzRG8tTmpEdkVkUmFhcUdfWmFjT2k1OHRVTFlrTX
📰 Actu.fr · 07/08/2020
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNdkp6dEl1ZjhzcVpDMGppWGVwVDQybHN4ZWMtM09JWDNiaTdWZWtrUTlpTEJ0bDNYbmUxMXdrSWQxUnFqbFgwU19TSy10VGV6RHp4cFZhME9HXzE0V0xIMUU4aDZGT05tUFpScWI0aG83dnRsRjVWaE84Y0Z3WXZSVDJTZmU5aUktdjRjTHl0VlVDMUZRT2F1MGNteGlxUkxwaEtnWmJZVDcxZ1NhZ1EtSXhadWRGNHB3cD
📰 Actu.fr · 26/02/2020
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNb0thVVNkYlNTM3lmVmJQOGh5ZHZrTlUxTW5jQng1SERmcWc3dnVfWGJvZTZGWXlBajZjbFFvSTBxM280ZGl2MnVHX19LeGV0TGkzODV3d0s2Q05oX0h5akd0NUJuN2ZSQWlSMFoxbnI5bGRZcF9uaGcybGI3RXFONVYwV3h5WUpxMHhEN1gtcFlzQ1diejNoNHBWQ3YxVjB2S1lCVHRRZEl0UzNJNFE?oc=5" target="
📰 pharmactuel.com · 07/12/2018
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE1GUzRKMWQwVTJJbHFObU5UdzR5YUVndVd6TE92NVhVNzQ3QTN0dzY2MzFfMThndGFxTEhYQVJtaDdqb2JWbXpETkRDTHFYc1ZmOFlJSWx3aV8xTy13eVU4U29nVTVOTFhrVjVQb2t1NU9xT0Ryd2c?oc=5" target="_blank">Réorganisation de la clinique externe d’oncologie : expérience du Ce
📰 Actu.fr · 02/05/2014
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPcGwyZzJ4NS1nZ0hKQmZvTTQ3WVQzWkhFTDZzUGp2NTktS0lIVVN2WkpoX0Vjc1BsOTZ0U3BXcnZKZmdGaFRHanI4YTVTTXY0XzF6RDh5ZHNGclBBV1ozNFdIYW1lYlEwSXVSMDU1eGdVd28tMGZkRXhGVUhtblJyWHJKZDlfTTFmZVdDeTBacTU4S0xKR2ltUXFLeG5OTkhBb0U5ZUpjS09KWUVNNFM2cHdQZTNKUzUwaG
Lancet (London, England) · 2024
Annals of surgery · 2020
Objective: The aim of this retrospective study was to compare portal vein embolization (PVE) and radiologica simultaneous portohepatic vein embolization (RASPE) for future liver remnant (FLR) growth in terms of feasibility, safety, and efficacy. Summary of Background Data: After portal vein embolization (PVE), 15% of patients remain ineligible for hepatic resection due to insufficient hypertrophy of the FLR. RASPE has been proposed to induce FLR growth. Materials and Methods: Between 2016 and 2018, 73 patients were included in the study. RASPE was proposed for patients with a ratio of FLR to total liver volume (FLR/TLV) of <25% (RASPE group). This group was compared to patients who underwent PVE for a FLR/TLV <30% (PVE group). Patients in the 2 groups were matched for age, sex, type of tumor, and number of chemotherapy treatments. FLR was assessed by computed tomography before and 4 weeks after the procedure. Results: The technical success rate in both groups was 100%. Morbidity post-embolization, and the time between embolization and surgery were similar between the groups. In the PVE group, the FLR/TLV ratio before embolization was 31.03% (range: 18.33%–38.95%) versus 22.91% (range: 16.55–32.15) in the RASPE group (P < 0.0001). Four weeks after the procedure, the liver volume increased by 28.98% (range: 9.31%–61.23%) in the PVE group and by 61.18% (range: 23.18%–201.56%) in the RASPE group (P < 0.0001). Seven patients in the PVE group, but none in the RASPE group, had postoperative liver failure (P = 0.012). Conclusions: RASPE can be considered as “radiological associating liver partition and portal vein ligation for staged hepatectomy.” RASPE induced safe and profound growth of the FLR and was more efficient than PVE. RASPE also allowed for extended hepatectomy with less risk of post-operative liver failure.
Gastroenterology & hepatology · 2018
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of the American Pharmacists Association : JAPhA · 2026 · Journal Article
Bacle A, Ferreira V, Pelletier S, Bouchard A, et al.
Diabetes & metabolism · 2025 · Journal Article
Larroumet A, Marichez A, Camoin M, Baillet-Blanco L, et al.
Clinical transplantation · 2025 · Journal Article
Bacle A, Blanc-Petitjean P, Demay E, Pelletier S, et al.
Clinics and research in hepatology and gastroenterology · 2025 · Case Reports
Marichez A, Aldajani N, Fleureau C, Adam JP, et al.
Annals of surgery · 2025 · Journal Article
Fouché D, Tzedakis S, Fuks D, Dewitte A, et al.
Transfusion · 2025 · Case Reports
Valin-Thorburn A, Desforges SM, Corsilli D, Guimond JG, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2025 · Journal Article
Pinard L, Adam JP, Chagnon M, Bollée G, et al.
Updates in surgery · 2025 · Journal Article
Chiche L, Marichez A, Rayar M, Simon A, et al.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024 · Journal Article
Marty C, Adam JP, Martel-Laferrière V, Doucet S, et al.
Oxford medical case reports · 2024 · Case Reports
Biddle K, Agaoglu E, Brent G, Adam J, et al.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2024 · Journal Article
Boubaddi M, Marichez A, Adam JP, Chiche L, et al.
Langenbeck's archives of surgery · 2023 · Journal Article
Marichez A, Fernandez B, Belaroussi Y, Mauriac P, et al.
HPB : the official journal of the International Hepato Pancreato Biliary Association · 2023 · Journal Article
Marichez A, Adam JP, Mauriac P, Passand GT, et al.
The Canadian journal of hospital pharmacy · 2023 · Journal Article
Marcellin A, Langevin MC, Adam JP
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2023 · Journal Article
Marineau A, St-Pierre C, Lessard-Hurtubise R, David MÈ, et al.
Langenbeck's archives of surgery · 2023 · Journal Article
Laurent C, Rayar M, Maulat C, Muscari F, et al.
HPB : the official journal of the International Hepato Pancreato Biliary Association · 2022 · Journal Article
Chiche L, Guieu M, Bachellier P, Suc B, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2021 · Journal Article
Boutin CA, Adam JP, Martel D, Doucet S, et al.
Annals of surgery · 2021 · Journal Article
Julien C, Le-Bail B, Ouazzani Touhami K, Frulio N, et al.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021 · Journal Article
Bégin AM, Monfette ML, Boudrias-Dalle É, Lavallée E, et al.
Clinical lymphoma, myeloma & leukemia · 2021 · Case Reports
Mohamed ZA, Pelletier S, Vintze-Geoffrion A, Lagacé-Nadon S, et al.
Current oncology (Toronto, Ont.) · 2021 · Guideline
Blais N, Adam JP, Nguyen J, Grégoire JC
Research in social & administrative pharmacy : RSAP · 2021 · Journal Article
Adam JP, Khazaka M, Charikhi F, Clervil M, et al.
Journal of shoulder and elbow surgery · 2020 · Journal Article
Adam J, Basil Ammori M, Isah I, Jeyam M, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2020 · Case Reports
Cai ZR, Lecours J, Adam JP, Marcil I, et al.
Current oncology (Toronto, Ont.) · 2020 · Case Reports
Moineau-Vallée K, Rinfret J, Luu Hoai MH, St-Louis V, et al.
Molecules (Basel, Switzerland) · 2020 · Journal Article
Kruppke B, Ray S, Alt V, Rohnke M, et al.
Current opinion in supportive and palliative care · 2020 · Journal Article
Desilets A, Adam JP, Soulières D
Annals of surgery · 2020 · Comparative Study
Laurent C, Fernandez B, Marichez A, Adam JP, et al.
The Canadian journal of hospital pharmacy · 2019 · Journal Article
Adam JP, Trudeau C, Pelchat-White C, Deschamps ML, et al.
BMC surgery · 2019 · Journal Article
Buscail E, Cauvin T, Fernandez B, Buscail C, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2019 · Case Reports
Boudrias-Dalle E, Cloutier M, Harvey M, Leblanc G, et al.
The Journal of biological chemistry · 2018 · Journal Article
McCarthy MT, Moncayo G, Hiron TK, Jakobsen NA, et al.
Journal for immunotherapy of cancer · 2018 · Case Reports
Acero Brand FZ, Suter N, Adam JP, Faulques B, et al.
Gastroenterology & hepatology · 2018 · Journal Article
Jencks DS, Adam JD, Borum ML, Koh JM, et al.
Gynecologic oncology · 2017 · Journal Article
Adam JP, Boumedien F, Letarte N, Provencher D
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2017 · Case Reports
Edwards N, Olinger E, Adam J, Kelly M, et al.
European journal of haematology · 2022 · Case Reports
Tremblay Z, Wong A, Otis AS, Pépin MA, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2020 · Case Reports
Hassan C, Correal F, Vézina G, Yelle L, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2020 · Case Reports
Taillefer VT, Pigeon M, Chen M, Larochelle C, et al.
Lancet (London, England) · 2024 · Journal Article
Adam R, Piedvache C, Chiche L, Adam JP, et al.
Hepatobiliary surgery and nutrition · 2022 · Editorial
Marichez A, Adam JP
BMC cancer · 2018 · Clinical Trial, Phase III
Mohkam K, Rayar M, Adam JP, Muscari F, et al.
Annals of surgical oncology · 2024 · Journal Article
Boubaddi M, Marichez A, Adam JP, Lapuyade B, et al.
American journal of pharmaceutical education · 2023 · Journal Article
Langlois H, Proulx LC, Villeneuve É, Adam JP
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022 · Journal Article
Martineau C, Turcotte MK, Otis N, Provost F, et al.
BJS open · 2023 · Multicenter Study
Hoogwater FJH, Kuipers H, de Meijer VE, Maulat C, et al.
HPB : the official journal of the International Hepato Pancreato Biliary Association · 2021 · Journal Article
Marichez A, Turrini O, Fernandez B, Garnier J, et al.
Leukemia research reports · 2026 · Journal Article
Taillefer VT, Emond M, Leblanc MH, Doucet S, et al.
The Journal of experimental medicine · 2024 · Journal Article
David C, Arango-Franco CA, Badonyi M, Fouchet J, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2020 · Case Reports
Hassan C, Correal F, Vézina G, Yelle L, et al.
Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy
BackgroundOutpatients treated with oral anti-cancer drugs, including selective cyclin-dependent kinase 4/6 inhibitors (CDK4/6i), may benefit from a pharmacy practice setting adapted to support proper oral anti-cancer dru
sj-pptx-1-opp-10.1177_10781552221102884 - Supplemental material for Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy
Supplemental material, sj-pptx-1-opp-10.1177_10781552221102884 for Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a c
Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy
BackgroundOutpatients treated with oral anti-cancer drugs, including selective cyclin-dependent kinase 4/6 inhibitors (CDK4/6i), may benefit from a pharmacy practice setting adapted to support proper oral anti-cancer dru
sj-pptx-1-opp-10.1177_10781552221102884 - Supplemental material for Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy
Supplemental material, sj-pptx-1-opp-10.1177_10781552221102884 for Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a c
Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy
BackgroundOutpatients treated with oral anti-cancer drugs, including selective cyclin-dependent kinase 4/6 inhibitors (CDK4/6i), may benefit from a pharmacy practice setting adapted to support proper oral anti-cancer dru
sj-pptx-1-opp-10.1177_10781552221102884 - Supplemental material for Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy
Supplemental material, sj-pptx-1-opp-10.1177_10781552221102884 for Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a c
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).